<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://dirros.openscience.si/IzpisGradiva.php?id=24410"><dc:title>Expression of inducible damage-associated molecular patterns after interleukin-12 gene electrotransfer in mouse melanoma and colorectal cell lines</dc:title><dc:creator>Medved,	Ajda	(Avtor)
	</dc:creator><dc:creator>Omerzel,	Maša	(Avtor)
	</dc:creator><dc:creator>Jesenko,	Tanja	(Avtor)
	</dc:creator><dc:creator>Buček,	Simon	(Avtor)
	</dc:creator><dc:creator>Serša,	Gregor	(Avtor)
	</dc:creator><dc:creator>Čemažar,	Maja	(Avtor)
	</dc:creator><dc:subject>gene electrotransfer</dc:subject><dc:subject>cytokine</dc:subject><dc:subject>interleukin-12</dc:subject><dc:description>Interleukin-12 (IL-12) has demonstrated potent antitumor effects by activating natural killer (NK) and T cells, but its systemic administration poses challenges due to toxicity. This study investigated gene electrotransfer (GET) as a localized delivery method for IL-12 plasmids in B16F10 and CT26 tumor cells and its effect on the expression of damage-associated molecular patterns (DAMPs) and several cytokines. We observed the activation of cytosolic sensors and cytokine production, with the expression of IL-6 and TNF-α upregulated only after IL-12 GET, suggesting the involvement of inducible damage-associated molecular patterns (iDAMPs) in the immune response to IL-12 gene therapy. These findings highlight the multifaceted immune activation triggered by GET, offering insights for improving IL-12-based cancer therapies.</dc:description><dc:publisher>Elsevier Masson SAS</dc:publisher><dc:date>2025</dc:date><dc:date>2025-11-27 03:58:38</dc:date><dc:type>Neznano</dc:type><dc:identifier>24410</dc:identifier><dc:language>sl</dc:language><dc:rights>by Authors</dc:rights></rdf:Description></rdf:RDF>
